Eisai

About Eisai

Eisai's US field force is split by business group. Oncology sales specialists promote their assigned brands in the oral and IV markets in a territory (LENVIMA among them, with product training built around liver and thyroid cancer), calling on medical oncologists, hematologists, endocrinologists and their nurses, pulling sales through integrated delivery networks and bringing in field reimbursement managers when access stalls, while area business leaders coach a team of those specialists and own the C-suite, pathway and P&T committee relationships at the health systems and cancer centers in their area. On the neurology side, neurology account specialists are hired for a US Alzheimer's launch aimed at mild cognitive impairment and mild disease (its site lists LEQEMBI and the LEQEMBI IQLIK injection): they map IDN stakeholders and referral paths, help hospitals toward formulary decisions and generate demand within the label, and the postings want infusion, buy and bill, specialty pharmacy, rare disease or neurology experience. Each territory posting carries qualifications for two grades, specialist and senior specialist, with the senior grade reached through defined promotion criteria, and every field seat needs a clean driving record and regular in-person access to prescribers, including whatever credentialing a hospital demands. Behind the field, a commercial training and development group in Nutley, New Jersey and remote hires leaders and managers for Alzheimer's field and sales training, oncology product training and market access and account management training.